Skip to content

Comparison of nishakatkadi ghan vati with oral hypoglycemic agent in the treatment of diabetes mellitus

A Randomized Controlled clinical study to evaluate an adjuvant effect of Nishakatkadi Ghan vati with oral Hypoglycemic agent in diabetes Mellitus (type2)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024195
Enrollment
60
Registered
2020-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: Nishakatkadi Ghan vati: Nishakatkadi Ghan vati is preapared by vati kalpana and will be givan orally 500mg before breakfast,lunch and dinner day with luke warm water which includes foll

Sponsors

Principal PDEAs college of Ayurved and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group between 35 years to 70 years 2.cases of both gender will be included 3.patient with fasting blood sugar upto 200 mg% and post parandial blood sugar 300mg%

Exclusion criteria

Exclusion criteria: 1.insulin dependent diabetes mellitus (IDDM)and those who are under insulin therapy. 2.patient with acute complications like hyperglycemic and hypoglycemic coma,ketoacidosis and related complication and infections like gangrene. 3.patient with chronic diabetic complications like Nephropathy,Neuropathy and Retinopathy. 4.pregnant and lactating woman. 5.patients suffering from all major systemic diseases

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Nishakatkadi Ghan Vati 500mg three times before breakfast,lunch and dinner a day for 3 months as an adjuvant medication to oral hypoglycemic agent in the management of diabetes mellitus type 2on basis of BSL and HbA1C valuesTimepoint: 90 Days with follow up on every 15th day

Secondary

MeasureTime frame
1.to study the effect of Nishakatkadi Ghan vati 90days. 2.to study the effect of oral Hypoglyacemic agent. 3.to observe the adverse effect if anyTimepoint: 90 days

Countries

India

Contacts

Public ContactDrMedha Mahesh Joshi

PDEAs college of ayurved and research centre akurdi

medhamaheshjoshi@gmail.com9881465798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026